Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > Virology
|
Not currently available
Case for Interferon - How a 1980s Cancer Drug Might Be the Wonder Therapy for the Twenty-First Century (Hardcover)
Loot Price: R578
Discovery Miles 5 780
You Save: R121
(17%)
|
|
Case for Interferon - How a 1980s Cancer Drug Might Be the Wonder Therapy for the Twenty-First Century (Hardcover)
(sign in to rate)
List price R699
Loot Price R578
Discovery Miles 5 780
You Save R121 (17%)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
Touted as a potential breakthrough cancer therapy in the 1980s by
the scientific community and publications such as TIME and Newsweek
magazine, the reputation of interferon has not lived up to its
early promise. Interferons are small proteins with anti-viral and
anti-cancer effects, which have the power to modulate the
functioning of the immune system. But Dr. Joseph Cummins, an early
interferon pioneer, holder of sixteen US medical patents, author of
more than sixty scientific publications, as well as having taught
veterinary medicine at the University of Missouri, University of
Illinois, and Texas A & M University, argues that the current
thinking on interferon is fundamentally flawed. Interferon is
created in small quantities in the body in response to infection,
and seems to work best at these low dosages. However, the public
health cowboys, working under the assumption that anything good in
tiny amounts must be better in massive amounts, pursued exactly the
wrong strategy. High-dose interferon does not work in the body and
may even cause problems. The first remarkable results for
interferon and the flu were reported by the Soviets in the 1970s,
but Western medicine discounted these findings because they
believed the dosages were so low they couldn't possibly be
effective. In the 1980s, when interferon was expensive to produce
and only small quantities could be manufactured, the results were
remarkable. Dr. Cummins was an early pioneer of low-dose
interferon, and his remarkable findings among animals led to
collaborations with medical doctors for human trials, even going so
far as Africa at the height of the HIV-AIDS epidemic. Cummins
reviews the evidence for this inexpensive, safe treatment and makes
an eloquent argument for medical science to take another look at
interferon to tackle today's most challenging health conditions,
including COVID-19.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.